Other options
view Contact Information
Contact Information for Olaparib and Durvalumab in Metastatic Triple Negative Breast Cancer
The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org
OHSU Knight Cancer Institute, Portland, OR, 97239
| Principal Investigator: | Alexandra Zimmer, M.D. |
| Contact person: | OHSU Knight Cancer Institut... |
| Phone: | 503-494-7999 |
| Email: | trials@ohsu.edu |
